Juvena Therapeutics is a venture-backed biotechnology company with a mission to unlock the therapeutic potential of secreted proteins and engineer them into life-saving therapeutics for chronic and age-related diseases. Their approach combines cutting-edge technologies such as Artificial Intelligence and in silico screening to map secreted proteins to specific disease phenotypes. By utilizing a compounding database, wetlab screening in primary human cell and animal models, and protein engineering capabilities, they aim to accelerate the development of regenerative biologics.

At Juvena Therapeutics, they have assembled a team of brilliant minds dedicated to unraveling the brilliance of the human body. Their expertise and innovative thinking drive the exploration and decoding of secreted proteins to improve human health. The company has gained recognition for its groundbreaking work, with CEO and co-Founder Dr.

Hanadie Yousef being named on prestigious lists such as Endpoints' 20 under 40 and Pharmaceutical Executive's Emerging Pharma Leaders. Their potential to expand the range of treatments for chronic conditions and diseases of aging has been acknowledged by The Wall Street Journal. To stay updated on their advancements and breakthroughs, you can subscribe to their newsletter.

Located in Redwood City, CA, Juvena Therapeutics is at the forefront of revolutionizing healthcare through their pioneering research and development